Naphthalene anti-psoriatic agents

Details Naphthalene anti-psoriatic agents Naphthalene anti-psoriatic agents

1987-03-09

1988-11-22

Garner, Vivian

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

N-c doai

514510, 514863, 558266, 558268, 560 29, 560 31, 560 32, 560115, 560134, 260396R, A61K 3127, A61K 31265, C07C 6996, C07C125075

Patent

active

047866527

ABSTRACT:
Psoriasis in mammals is relieved by topically administering naphthalenes of the formula: ##STR1## wherein: R.sup.1 is lower alkoxy or optionally substituted phenoxy,

REFERENCES:
patent: 2383392 (1945-08-01), Karrer
patent: 3935267 (1976-01-01), Hauck et al.
patent: 3958006 (1976-05-01), Payne
patent: 4181741 (1980-01-01), Bullock
patent: 4229478 (1980-10-01), Jones et al.
patent: 4466981 (1984-08-01), Jones et al.
patent: 4593120 (1986-06-01), Jones et al.
Alkoxy Exchange Reactions of Naphthalene Ethers, by J. E. Baldwin, et al. Journal of Organic Chemistry, vol. 34, 2788-2790.

Affiliated with

Also associated with

Rating

Naphthalene anti-psoriatic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Naphthalene anti-psoriatic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalene anti-psoriatic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-435635